Company Profile
Updated: 27-OCT-09Helsinn Healthcare S.A.
International Private company
Via Lucino 3, Pazzallo, Breganzona, CH-6932, Switzerland
()41 091 985 21 21, 41 091 993 21 22 fax, http://www.helsinn.ch
Primary SIC: Commercial Physical & Bio Research, Primary NAICS: Research and Development in the Physical Sciences and Engineering Sciences
Description: Services: Development, licensing and marketing of new pharmaceutical products, including Active Pharmaceutical Ingredients and High Potency Active Ingredients. The Group comprises three divisions: Integrated Manufacturing, Integrated Licensing and Irish Pharmaceuticals
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
Other News To Note.
BIOWORLD Today; 11/4/2009; 1242 words; ...investigate the product's safety, 35 individuals...of Minneapolis, and Helsinn Healthcare SA, of Lugano, Switzerland...plans to be ready for U.S. launch of the differentiated...headache and constipation. Helsinn, which owns the worldwide...
MGI Offering Could Gross $128M Following FDA Approval Of Aloxi.
BIOWORLD Today; 11/4/2009; 1279 words; ...would generate the lion's share of that projection...about $38 million for U.S. and Canadian marketing...development was fully funded by Helsinn Healthcare SA. The Lugano, Switzerland...compliance issues, it's as safe or safer and it...
MGI's Irofulven Phase III Pancreatic Trial Stopped; Stock Tumbles.
BIOWORLD Today; 11/4/2009; 1173 words; ...successfully,o Gerber said. MGI Pharma is partnered with Helsinn Healthcare SA, of Lugano, Switzerland, in a deal struck in April 2001, giving MGI the exclusive U.S. and Canadian licensing and distribution rights to palonosetron...
Helsinn Announces Completion of its new Stability Centre at its Irish Drug Product Manufacturing Facility.
Biotech Week; 11/4/2009; 521 words; ...important addition to Helsinn's capability to monitor the quality...Additionally, it complements Helsinn's capabilities to optimize its product...development process." Keywords: Helsinn Healthcare Sa, Pharmaceuticals. This article...
MGI Raises $156.2M Publicly To Fund Oncology Drugs, Purchases.
BIOWORLD Today; 11/4/2009; 913 words; ...company has projected Aloxi's sales to generate $40...which is partnered with Helsinn Healthcare SA, was approved to prevent...about $38 million for U.S. and Canadian marketing...application late last year, Helsinn reported Phase III data...
Recent News Articles
- Helsinn Healthcare SA Announces Partnering Agreement for ZP1846, a Novel GLP-2 Agonist from Zealand Pharma.
Business Wire - December 11, 2008 - Helsinn Healthcare and Zealand Pharma Sign a Partnering Agreement for ZP1846, a Novel GLP-2 Agonist.
PR Newswire - November 27, 2008 - Eisai/Helsinn's Aloxi capsules approved in USA.(Helsinn Healthcare SA)(Brief article)
Pharma Marketletter - September 01, 2008 - Helsinn Healthcare's Aloxi launched in UK.
Pharma Marketletter - February 18, 2008
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning